Answers are grounded in this paper and cite their sources.
In vitro analysis reveals altered NKG2D expression in immune cells from Behçet syndrome patients, indicating potential treatment implications.
Drugs used in the management of BS reduced NKG2D expression, potentially decreasing the activation of cytotoxic cells. Immune cells from BS patients responded differently to dexamethasone and colchicine compared to those from CTR.
No takes yet. Share an insight, caveat, or question.
Bonacini et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: